Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
842 RESULTS FOUND
Coverage, Coding and Reimbursement Policies for Medical Technologies
April 9, 2018 | Infographic
AdvaMed Comments On Docket No. FDA-2017-N-4301: Fostering Medical Innovation: A Plan for Digital Health Devices; Software Precertification Pilot Program
April 6, 2018 | Comments
Trade Policy 101 Tutorial for AdvaMed Members
April 2, 2018 | Agenda
AdvaMed Comments On Docket No. FDA-2017-N-6356FDA-2017-D-5570; Draft Guidance on Select Updates for Recommendations for CLIA of 1988 Waiver Applications for Manufacturers of IVD Devices
March 30, 2018 | Comments
AdvaMed Comments On Docket No. FDA-2017-D-5625-0002; Draft Guidance on Recommendations for Dual 510(k) and CLIA Waiver by Application Studies
March 30, 2018 | Comments
FDA Requirements for Medical Technology
March 28, 2018 | Infographic
AdvaMed Comments on Docket No. FDA-2017-D-6765; Draft Guidance for Industry and Food and Drug Administration Staff; Replacement Reagent and Instrument Family Policy for In Vitro Diagnostic Devices
March 21, 2018 | Comments
AdvaMed Comments On Docket No. FDA-2017-N-6356; Draft Guidance for Industry, Food and Drug Administration Staff, Sponsors and Institutional Review Boards; Investigational IVD Used in Clinical Investigations of Therapeutic Products
March 21, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2016-D-3548: Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C; Draft Guidance for Industry and Food and Drug Administration Staff
March 20, 2018 | Comments
AdvaMed Comments on Re: Input for the Food and Drug Administration’s Consideration in Developing Draft Guidance To Implement Section 702 of the of the Food and Drug Administration Reauthorization Act
March 9, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2017-D-6702: The Least Burdensome Provisions: Concept and Principles
March 9, 2018 | Comments
Use Case: Application of the Medtech Value Assessment Framework to Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer
March 8, 2018 | White Paper
AdvaMed 2018 AKS Safe Harbor Proposals for Value-Based Arrangements
February 27, 2018 | Letter
AdvaMed Comments on NIST Special Publication 2000–01: ABC’s of Conformity Assessment
February 27, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2017-N-6730: Voluntary Malfunction Summary Reporting Program for Manufacturers, Notice and Request for Comments
February 26, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2017-N-5319: Devices Proposed for a New Use with an Approved Marketed Drug: Public Heating; Request for Comments
February 21, 2018 | Comments
2018 NIH CAP DC Company Descriptions Alphabetical
February 9, 2018 | Summary
2018 NIH CAP DC FeedForward Session Company Presenting Schedule
February 9, 2018 | Agenda
AdvaMed Comments on Docket Number FDA-2015-N-2002-2008: Amendments to Regulations Regarding “Intended Uses”; Partial Delay of Effective Date
February 6, 2018 | Comments
AdvaMed Comments On Docket Number FDA-2017-N-5105: Review of Existing Center for Devices and Radiological Health Regulatory and Information Collection Requirements
February 6, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2017-D-6569: Clinical and Patient Decision Support Software: Draft Guidance for Industry and Food and Drug Administration Staff
February 6, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2017-D-6294: Changes to Existing Medical Software Policies Resulting From Section 3060 of the 21st Century Cures Act; Draft Guidance for Industry and Food and Drug Administration Staff
February 6, 2018 | Comments
Combatting America's Opioid Epidemic with Medical Technology
February 5, 2018 | White Paper
University Technology Transfer Fireside Chat Agenda
February 1, 2018 | Agenda
IFC Health Presentation on Medtech Investment and Support in Emerging Markets
January 30, 2018 | Presentation

Pages